Cumberland Pharmaceuticals (CPIX) vs Kazia Therapeutics (KZIA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cumberland Pharmaceuticals (CPIX) has outperformed Kazia Therapeutics (KZIA) over the past year, gaining 90.2% versus a gain of 23.2%. Over five years, CPIX leads with a +154.7% price change compared with -98.3% for KZIA. Cumberland Pharmaceuticals is the larger company by market cap ($104.6 million vs $100.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CPIX | KZIA |
|---|---|---|
| Share price | $6.98 | $8.82 |
| Market cap | $104.58M | $100.79M |
| 1-day change | +1.31% | -5.06% |
| YTD return | +75.38% | +28.01% |
| 1-year return | +90.19% | +23.18% |
| 5-year return | +154.74% | -98.32% |
| Forward P/E | 49.86 | — |
| EPS (TTM) | $-0.62 | $-6.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.28 | $17.40 |
| 52-week low | $1.85 | $4.86 |
| Distance from 52-week high | -24.78% | -49.31% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +220.41% |
| Average volume | 87.71K | 262.15K |
| Shares outstanding | 14.98M | 11.43M |
| Employees | 88 | 6 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CPIX has outperformed KZIA by 67.0 percentage points over the past year.
About Cumberland Pharmaceuticals
CPIX stock →Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.
Healthcare · Drug Manufacturers - Specialty & Generic · 88 employees
About Kazia Therapeutics
KZIA stock →Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors.
Healthcare · Biotechnology · 6 employees
CPIX vs KZIA FAQ
Which is bigger, Cumberland Pharmaceuticals or Kazia Therapeutics?
Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $104.58M compared with $100.79M for Kazia Therapeutics (KZIA).
Which stock has performed better over the past year, CPIX or KZIA?
CPIX returned +90.19% over the past 12 months, compared with +23.18% for KZIA (price return, excluding dividends). Past performance does not predict future results.
Are Cumberland Pharmaceuticals and Kazia Therapeutics in the same industry?
Both are in the Healthcare sector, but in different industries: Drug Manufacturers - Specialty & Generic for Cumberland Pharmaceuticals and Biotechnology for Kazia Therapeutics.